			Home About us Contact

Eye Complications (eye + complications)

Distribution by Scientific Domains

Medical Sciences	100%

Selected Abstracts

Design, surgical technique and complications MOOKP

ACTA OPHTHALMOLOGICA, Issue 2009
GC FALCINELLI
Purpose To describe design, surgical technique of the modified osteo-odonto-keratoprosthesis (MOOKP),originated from Strampelli's OOKP, with the modifications and the innovations made by Falcinelli, between these thoseones of the last years to the first stage of the procedure, never published. Methods First stage:abstraction of the mono-rooted tooth with surrounding root and bone. Preparation of the lamina to which, in the dentine central part,the PMMA optic cylinder is glued.Burying of the lamina for 3 months (subcutaneoos pocket). New modification:opening of the A.C., complete removal of the iris, lens cryo-extraction,anterior vitrectomy.Intermediate stage: after 1 month covering of the eye surface by buccal mucosa. Final stage: after3 months implant of the lamina on the eye with insertion in A.C. of the cylinder after corneal trephining,covering with buccal mucosa previously detached. Results MOOKP COMPLICATIONS- 1- Intraoperative, easy to be cured. 2- After the 1st stage and intermediate stage: all easily treatable. 3- After the prosthesis implant, more severe: a) Prosthesis complications which affect mainly the mucosa, easy to be cured, or the lamina and the cylinder, more rare, difficult to be cured. b) Eye complications: retinal detachment, not frequent and easily cured. Retroprosthetic membranes, very rare. Endophthalmites, very difficult to treat, fortunately rare. Conclusion Biological properties Strampelli's osteo-odonto lamina (OOL)with Falcinelli's surgical modifications make of MOOKP a KPro with best results, teorically without duration limits in the less and in the very severe cases of corneal and anterior oculare surfice alterations like the last stage of dray eye. [source]

Glaucoma induced by periorbital topical steroid use , a rare complication

CLINICAL & EXPERIMENTAL DERMATOLOGY, Issue 6 2004
D. Sahni
Summary Eye complications arising during systemic and ophthalmic steroid use are well known. In contrast, there is little highlighting the similar risks associated with topical steroid use around the eyelids. We now describe a 29-year-old lady who used topical steroids in prolonged fashion throughout most of her life for severe eczema, with the recent application of large quantities of potent steroid continuously for one month, including to the periorbital region. Soon after, she presented to her ophthalmologist with severe bilateral glaucoma and irreversible visual loss attributed to the steroid use. Here we emphasise the possible risks of periorbital topical steroid use, as well as the importance of patient education and ophthalmological follow-up. [source]

Psoriasis and the eye: Prevalence of eye disease in Singaporean Asian patients with psoriasis

THE JOURNAL OF DERMATOLOGY, Issue 12 2007
Nisha S. CHANDRAN
ABSTRACT There is little published data on the incidence of eye disease in Asian patients with psoriasis. We determined the frequency of ocular complications in Singaporean Asian patients with chronic plaque psoriasis and related these to extent and severity of psoriasis, family history, treatment and presence of arthritis. A cross-sectional prevalence investigation was carried out in 100 patients who received a comprehensive eye examination. Psoriasis extent and severity was graded by the Lattice System Physician's Global Assessment (LS-PGA). Two patients (four eyes) had uveitis, one of whom had psoriatic arthritis (2% incidence). Presence or absence of uveitis correlated with mean LS-PGA scores. Sixty-three patients had cataract unrelated to previous steroid or phototherapy treatment; in younger (<50 years) patients they were commoner than in those with higher (>5) LS-PGA scores. Three eyes in two patients (2% prevalence) had glaucomatous optic neuropathy unrelated to previous treatment, and comparable with expected population frequency. These findings, although limited by lack of data from a comparable control population, suggest that eye complications are common in Asian patients with psoriasis and eye symptoms should be elicited during history taking. Besides signs and symptoms of eye disease, an LS-PGA score of more than 5 should prompt referral for ophthalmological examination. [source]

Erythropoietic protoporphyria with eye complications

THE JOURNAL OF DERMATOLOGY, Issue 11 2007
Hiromi TSUBOI
ABSTRACT We herein report a case of erythropoietic protoporphyria (EPP) complicated by a decrease in eyesight that occurred in a Japanese male. An ophthalmologist initially thought that the eyesight loss might be the result of idiopathic optic nerve atrophy due to a vascular obstruction in the fundus. There are no previous reports of EPP cases with eye complications. However, an eye abnormality has been reported in an animal model of protoporphyria after long-term, low-level exposure to blue light. As a result, in our case, it is therefore possible that a relationship may have existed between EPP and the onset of eye complications. [source]

Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review

ACTA OPHTHALMOLOGICA, Issue 6 2009
Nils Eide
Abstract. Ocular oncologists require a strong indication for intraocular biopsy before the procedure can be performed because it carries a risk for serious eye complications and the dissemination of malignant cells. The purpose of this review is to evaluate the extent to which this restricted practice is supported by evidence from previous reports and to outline our main indications and contraindications. The different intraocular biopsy techniques in the anterior and posterior segment are discussed with a focus on our preferred method, fine-needle aspiration biopsy (FNAB). In the literature, complications are typically under-reported, which reduces the possibilities of evaluating the risks correctly and of making fair comparisons with other biopsy methods. In FNAB, the exact placement of the needle is critical, as is an accurate assessment of the size of the lesion. Fine-needle aspiration biopsy is usually not a reliable diagnostic tool in lesions < 2 mm in thickness. It is very advantageous to have a cytopathologist present in the operating theatre or close by. This ensures adequate sampling and encourages repeated biopsy attempts if necessary. This approach reduces false negative results to < 3%. Adjunct immunocytochemistry is documented to increase specificity and is essential for diagnosis and management in about 10% of cases. In some rare pathological processes the diagnosis depends ultimately on the identification of specific cell markers. An accurate diagnosis may have a decisive influence on prognosis. The cytogenetic prognostications made possible after FNAB are reliable. Biopsy by FNA has a low complication rate. The calculated risk for retinal detachment is < 4%. Intraocular haemorrhage is frequently observed, but clears spontaneously in nearly all cases. Only a single case of epibulbar seeding of malignant cells at the scleral pars plana puncture site of transvitreal FNAB has been documented. Endophthalmitis has been reported and adequate standard preoperative preparation is obligatory. An open biopsy is still an option in the anterior segment, but has been abandoned in the posterior segment. Although vitrectomy-based procedures are becoming increasingly popular, we recommend using FNAB as part of a stepwise approach. A vitrectomy-assisted biopsy should be considered in cases where FNAB fails. In any adult patient with suspected intraocular malignancy in which enucleation is not the obvious treatment, the clinician should strive for a diagnosis based on biopsy. When the lesion is too small for biopsy or the risks related to the procedure are too great, it is reasonable to be reluctant to biopsy. The standards applied in the treatment of intraocular malignant diseases should be equivalent to those in other fields of oncology. Our view is controversial and contrary to opinion that supports current standards of care for this group of patients. [source]